Royalty Pharma PLCNASDAQ:RPRX
- LAST PRICE26.6300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots26.5000/ 2
- Ask / Lots26.7000/ 4
- Open / Previous Close26.3000 / 26.6300
- Day Range
- 52 Week Range
- Volume1,606,201
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RPRX |
|---|---|---|
| 09:32 ET | 46445 | 26.405 |
| 09:34 ET | 6858 | 26.245 |
| 09:36 ET | 3414 | 26.195 |
| 09:38 ET | 2621 | 26.175 |
| 09:39 ET | 1560 | 26.2 |
| 09:41 ET | 7751 | 26.22 |
| 09:43 ET | 3628 | 26.215 |
| 09:45 ET | 2139 | 26.2696 |
| 09:48 ET | 3597 | 26.22 |
| 09:50 ET | 8125 | 26.1501 |
| 09:52 ET | 3445 | 26.16 |
| 09:54 ET | 350 | 26.1655 |
| 09:56 ET | 1437 | 26.18 |
| 09:57 ET | 1657 | 26.1605 |
| 09:59 ET | 1200 | 26.22 |
| 10:01 ET | 7058 | 26.27 |
| 10:03 ET | 3284 | 26.31 |
| 10:06 ET | 3480 | 26.29 |
| 10:08 ET | 3560 | 26.29 |
| 10:10 ET | 6408 | 26.29 |
| 10:12 ET | 1800 | 26.305 |
| 10:14 ET | 1424 | 26.305 |
| 10:15 ET | 33674 | 26.285 |
| 10:17 ET | 15766 | 26.34 |
| 10:19 ET | 3090 | 26.42 |
| 10:21 ET | 7706 | 26.365 |
| 10:24 ET | 999 | 26.375 |
| 10:26 ET | 7229 | 26.325 |
| 10:28 ET | 1675 | 26.375 |
| 10:30 ET | 4437 | 26.38 |
| 10:32 ET | 3400 | 26.37 |
| 10:33 ET | 3470 | 26.345 |
| 10:35 ET | 3346 | 26.35 |
| 10:37 ET | 2051 | 26.325 |
| 10:39 ET | 8595 | 26.325 |
| 10:42 ET | 2457 | 26.325 |
| 10:44 ET | 3116 | 26.33 |
| 10:46 ET | 5850 | 26.32 |
| 10:48 ET | 1839 | 26.305 |
| 10:50 ET | 11739 | 26.325 |
| 10:51 ET | 3276 | 26.325 |
| 10:53 ET | 2881 | 26.32 |
| 10:55 ET | 1141 | 26.315 |
| 10:57 ET | 5252 | 26.335 |
| 11:00 ET | 16913 | 26.3 |
| 11:02 ET | 2333 | 26.285 |
| 11:04 ET | 2374 | 26.325 |
| 11:06 ET | 836 | 26.345 |
| 11:08 ET | 2307 | 26.375 |
| 11:09 ET | 2225 | 26.405 |
| 11:11 ET | 6270 | 26.42 |
| 11:13 ET | 2156 | 26.44 |
| 11:15 ET | 1368 | 26.445 |
| 11:18 ET | 9678 | 26.475 |
| 11:20 ET | 4050 | 26.46 |
| 11:22 ET | 2727 | 26.4446 |
| 11:24 ET | 1368 | 26.455 |
| 11:26 ET | 3580 | 26.445 |
| 11:27 ET | 1945 | 26.445 |
| 11:29 ET | 3660 | 26.445 |
| 11:31 ET | 493 | 26.445 |
| 11:33 ET | 1935 | 26.465 |
| 11:36 ET | 6243 | 26.465 |
| 11:38 ET | 6539 | 26.465 |
| 11:40 ET | 1219 | 26.47 |
| 11:42 ET | 4288 | 26.51 |
| 11:44 ET | 1439 | 26.5 |
| 11:45 ET | 132 | 26.505 |
| 11:47 ET | 546 | 26.515 |
| 11:49 ET | 1831 | 26.52 |
| 11:51 ET | 4865 | 26.535 |
| 11:54 ET | 847 | 26.535 |
| 11:56 ET | 6047 | 26.525 |
| 11:58 ET | 715 | 26.525 |
| 12:00 ET | 1300 | 26.535 |
| 12:02 ET | 6131 | 26.545 |
| 12:03 ET | 5450 | 26.535 |
| 12:05 ET | 517 | 26.535 |
| 12:07 ET | 7570 | 26.545 |
| 12:09 ET | 4716 | 26.515 |
| 12:12 ET | 1599 | 26.515 |
| 12:14 ET | 640 | 26.515 |
| 12:16 ET | 7096 | 26.505 |
| 12:18 ET | 3506 | 26.5044 |
| 12:20 ET | 1699 | 26.495 |
| 12:21 ET | 7651 | 26.525 |
| 12:23 ET | 4812 | 26.52 |
| 12:25 ET | 10818 | 26.495 |
| 12:27 ET | 2516 | 26.495 |
| 12:30 ET | 4222 | 26.51 |
| 12:32 ET | 6116 | 26.535 |
| 12:34 ET | 6299 | 26.58 |
| 12:36 ET | 14131 | 26.555 |
| 12:38 ET | 3432 | 26.55 |
| 12:39 ET | 1900 | 26.56 |
| 12:41 ET | 3283 | 26.5499 |
| 12:43 ET | 1916 | 26.55 |
| 12:45 ET | 2412 | 26.555 |
| 12:48 ET | 600 | 26.56 |
| 12:50 ET | 786 | 26.56 |
| 12:52 ET | 11741 | 26.545 |
| 12:54 ET | 2022 | 26.51 |
| 12:56 ET | 2246 | 26.525 |
| 12:57 ET | 1871 | 26.535 |
| 12:59 ET | 5272 | 26.54 |
| 01:01 ET | 2760 | 26.535 |
| 01:03 ET | 5037 | 26.55 |
| 01:06 ET | 900 | 26.56 |
| 01:08 ET | 6886 | 26.555 |
| 01:10 ET | 42142 | 26.515 |
| 01:12 ET | 700 | 26.51 |
| 01:14 ET | 3366 | 26.5046 |
| 01:15 ET | 2779 | 26.505 |
| 01:17 ET | 1944 | 26.49 |
| 01:19 ET | 1658 | 26.48 |
| 01:21 ET | 1877 | 26.48 |
| 01:24 ET | 7487 | 26.505 |
| 01:26 ET | 820 | 26.5 |
| 01:28 ET | 2216 | 26.52 |
| 01:30 ET | 1523 | 26.525 |
| 01:32 ET | 1059 | 26.535 |
| 01:33 ET | 8342 | 26.54 |
| 01:35 ET | 2905 | 26.5697 |
| 01:37 ET | 2930 | 26.515 |
| 01:39 ET | 1400 | 26.515 |
| 01:42 ET | 2210 | 26.525 |
| 01:44 ET | 3515 | 26.565 |
| 01:46 ET | 4088 | 26.575 |
| 01:48 ET | 6251 | 26.575 |
| 01:50 ET | 4790 | 26.565 |
| 01:51 ET | 2056 | 26.565 |
| 01:53 ET | 3323 | 26.56 |
| 01:55 ET | 9295 | 26.615 |
| 01:57 ET | 3488 | 26.61 |
| 02:00 ET | 4014 | 26.61 |
| 02:02 ET | 305 | 26.615 |
| 02:04 ET | 5782 | 26.58 |
| 02:06 ET | 3024 | 26.59 |
| 02:08 ET | 3811 | 26.5848 |
| 02:09 ET | 1021 | 26.59 |
| 02:11 ET | 400 | 26.59 |
| 02:13 ET | 6483 | 26.595 |
| 02:15 ET | 3020 | 26.58 |
| 02:18 ET | 4168 | 26.59 |
| 02:20 ET | 2126 | 26.595 |
| 02:22 ET | 3723 | 26.605 |
| 02:24 ET | 3223 | 26.6 |
| 02:26 ET | 1762 | 26.615 |
| 02:27 ET | 2711 | 26.605 |
| 02:29 ET | 2554 | 26.605 |
| 02:31 ET | 4187 | 26.625 |
| 02:33 ET | 877 | 26.625 |
| 02:36 ET | 10953 | 26.63 |
| 02:38 ET | 600 | 26.625 |
| 02:40 ET | 1763 | 26.62 |
| 02:42 ET | 3700 | 26.63 |
| 02:44 ET | 16072 | 26.6302 |
| 02:45 ET | 1041 | 26.635 |
| 02:47 ET | 500 | 26.635 |
| 02:49 ET | 2475 | 26.635 |
| 02:51 ET | 9651 | 26.65 |
| 02:54 ET | 789 | 26.65 |
| 02:56 ET | 2662 | 26.65 |
| 02:58 ET | 942 | 26.655 |
| 03:00 ET | 8719 | 26.655 |
| 03:02 ET | 1313 | 26.655 |
| 03:03 ET | 2500 | 26.62 |
| 03:05 ET | 577 | 26.605 |
| 03:07 ET | 1862 | 26.6 |
| 03:09 ET | 1944 | 26.615 |
| 03:12 ET | 692 | 26.605 |
| 03:14 ET | 746 | 26.605 |
| 03:16 ET | 620 | 26.605 |
| 03:18 ET | 4016 | 26.605 |
| 03:20 ET | 4920 | 26.606 |
| 03:21 ET | 2100 | 26.62 |
| 03:23 ET | 4552 | 26.61 |
| 03:25 ET | 1686 | 26.615 |
| 03:27 ET | 2317 | 26.62 |
| 03:30 ET | 1763 | 26.62 |
| 03:32 ET | 4187 | 26.595 |
| 03:34 ET | 5472 | 26.605 |
| 03:36 ET | 2917 | 26.63 |
| 03:38 ET | 8081 | 26.62 |
| 03:39 ET | 8983 | 26.655 |
| 03:41 ET | 4635 | 26.645 |
| 03:43 ET | 5951 | 26.635 |
| 03:45 ET | 8041 | 26.63 |
| 03:48 ET | 5495 | 26.6 |
| 03:50 ET | 10355 | 26.625 |
| 03:52 ET | 14382 | 26.665 |
| 03:54 ET | 10259 | 26.675 |
| 03:56 ET | 21830 | 26.64 |
| 03:57 ET | 29109 | 26.645 |
| 03:59 ET | 43785 | 26.63 |
Jun 4, 2024
Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference, from 4:15PM ET on Tuesday Jun 04, 2024 by Dow Jones
4:15PM ET on Tuesday Jun 04, 2024 by Dow Jones
Jun 3, 2024
Press Release: Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes, from 5:15PM ET on Monday Jun 03, 2024 by Dow Jones
5:15PM ET on Monday Jun 03, 2024 by Dow JonesRoyalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes, from 5:15PM ET on Monday Jun 03, 2024 by Dow Jones
5:15PM ET on Monday Jun 03, 2024 by Dow JonesDJ Royalty Pharma Cut to Neutral From Buy by UBS, from 12:00PM ET on Monday Jun 03, 2024 by Dow Jones
12:00PM ET on Monday Jun 03, 2024 by Dow Jones
May 29, 2024
DJ S&P 500 Futures Fall In Premarket Trading; Bank OZK, American Airlines Group Lag, from 7:30AM ET on Wednesday May 29, 2024 by Dow Jones
7:30AM ET on Wednesday May 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Royalty Pharma PLC | 15.7B | 14.9x | +1.83% |
Amneal Pharmaceuticals Inc | 2.1B | -12.0x | --- |
Catalent Inc | 10.0B | -8.5x | --- |
Jazz Pharmaceuticals PLC | 7.1B | 22.1x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.2B | 15.6x | --- |
Company Information
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Contact Information
- Headquarters
- 110 East 59th StreetNEW YORK, NY, United States 10022
- Phone
- 212-883-0200
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Pablo Legorreta
- Vice Chairman, Executive Vice President
- Christopher Hite
- Chief Financial Officer, Executive Vice President
- Terrance Coyne
- Executive Vice President - Investments and Chief Legal Officer
- George Lloyd
- Executive Vice President - Research and Investments
- Marshall Urist
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $15.7B |
|---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 3.15% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.46 |
EPS | $1.78 |
Book Value | $14.61 |
P/E Ratio | 14.9x |
Price/Sales (TTM) | 7.0 |
Price/Cash Flow (TTM) | 13.2x |
Operating Margin | 41.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
